Registered entities
ABata
Reg. No. 40203173955Latvia
Investor mix
7 investors on record; lead investors include Bristol-Myers Squibb, Third Rock Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Other / undisclosed | 2 | 29% |
Developer of cell therapies for autoimmune and inflammatory disease
7 investors on record; lead investors include Bristol-Myers Squibb, Third Rock Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Other / undisclosed | 2 | 29% |